Template:Atrial fibrillation: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 71: Line 71:
!
!
[[Atrial fibrillation differential diagnosis|Differentiating Atrial fibrillation from other Diseases]]
[[Atrial fibrillation differential diagnosis|Differentiating Atrial fibrillation from other Diseases]]
|-
!
|- bgcolor="Pink"
!
Special Groups
: [[Postoperative atrial fibrillation|Post-operative AF]]
: [[Atrial fibrillation acute myocardial infarction|Acute Myocardial Infarction]]
: [[Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes|Wolff-Parkinson-White Pre-excitation Syndrome]]
: [[Atrial fibrillation hyperthyroidism|Hyperthyroidism]]
: [[Atrial fibrillation pregnancy|Pregnancy]]
: [[Atrial fibrillation hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]]
: [[Atrial fibrillation pulmonary diseases|Pulmonary Diseases]]
|-  
|-  
!
!
Line 136: Line 149:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Atrial fibrillation medical therapy|Medical Therapy]]
[[Atrial fibrillation urgent treatment|Urgent Treatment]]
|-  
|-  
!
!
Line 142: Line 155:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Atrial fibrillation surgery|Surgery]]
[[Atrial fibrillation overview of treatment|General Treatment Strategies]]
|-  
|-  
!
!
Line 148: Line 161:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Atrial fibrillation primary prevention|Primary Prevention]]
[[Atrial fibrillation anticoagulation|Anticoagulation]]
: [[Warfarin]]
: [[Dabigatran]]
|-  
|-  
!  
!  
Line 154: Line 169:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Atrial fibrillation secondary prevention|Secondary Prevention]]
Rate Control
: [[Atrial fibrillation maintenance of sinus rhythm|Maintenance of Sinus Rhythm]]
: [[Atrial fibrillation cardioversion|Cardioversion]]
: [[Atrial fibrillation invasive treatment|Invasive Treatment]]
: [[Atrial fibrillation surgical treatment|Surgery]]
|-
!
 
|- bgcolor="PaleTurquoise"
!
[[Atrial fibrillation follow-up and secondary prevention|Secondary Prevention]]
|-
!
 
|- bgcolor="PaleTurquoise"
!
[[Atrial fibrillation clinical trial data|Landmark Trials]]
|-  
|-  
!  
!  

Revision as of 19:20, 30 October 2011